Gynofort (Butoconazole Nitrate)

Gynofort is indicated for the treatment of vulvovaginal candidiasis, a common yeast infection affecting the female genital tract. It is used when a short course of local antifungal therapy is required.

• Treatment of acute vulvovaginal candidiasis caused by Candida species.
• Management of recurrent yeast infections when prescribed by a healthcare professional.
• Adjunct therapy for mixed bacterial‑fungal vaginal infections, as directed.
• Use in women who prefer a single‑dose intravaginal tablet regimen.
• Therapeutic option for patients who cannot tolerate oral antifungal agents.

The safety profile of Gynofort reflects the typical reactions observed with topical imidazole antifungals. Most side effects are mild and transient, while rare events may require medical attention.

Common

• Mild vaginal irritation or burning sensation.
• Transient itching or discomfort at the application site.
• Light vaginal discharge with a slight odor.

Serious

• Severe allergic reaction such as rash, hives, or swelling.
• Persistent or worsening vaginal pain or ulceration.
• Signs of systemic infection like fever or chills.

Before using Gynofort, certain conditions and patient factors should be considered to ensure safe and effective therapy.

• Confirm diagnosis of candidiasis before initiating treatment.
• Do not use if there is known hypersensitivity to butoconazole or other imidazoles.
• Avoid use during active vaginal bleeding or trauma.
• Consult a healthcare provider if pregnant or planning pregnancy.
• Use only as prescribed; do not exceed the recommended dose.
• Report any persistent irritation or unexpected symptoms promptly.

Butoconazole nitrate may interact with other medications applied intravaginally or systemic agents that affect fungal flora.

Avoid

• Concurrent use of other vaginal antifungal or spermicidal products.
• Combination with systemic azole antifungals without medical supervision.
• Use with vaginal douches or antiseptic washes during therapy.

Use with caution

• Topical corticosteroids applied to the vagina, which may mask irritation.
• Hormonal contraceptives that alter vaginal pH.
• Systemic immunosuppressants that increase risk of fungal overgrowth.